21 cases reports on haemangioma of spleen
The growing activity of hemangioma of spleen keeps unknown. To search theoretical basis for whether to take the operation, this study analyzed clinical data of 21 hemangioma patients, and 16 surgical specimens were analyzed immunohistochemistry of Ki-67, Bcl-2 and vascular endothelial growth factor...
Gespeichert in:
| Veröffentlicht in: | Journal of cancer research and therapeutics 2016-10, Vol.12 (4), p.1323-1323 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1323 |
|---|---|
| container_issue | 4 |
| container_start_page | 1323 |
| container_title | Journal of cancer research and therapeutics |
| container_volume | 12 |
| creator | Huang, Yuan Mu, Guangchuan Qin, Xingan Lin, Jinling Li, Shaosen Zeng, Yanjun |
| description | The growing activity of hemangioma of spleen keeps unknown. To search theoretical basis for whether to take the operation, this study analyzed clinical data of 21 hemangioma patients, and 16 surgical specimens were analyzed immunohistochemistry of Ki-67, Bcl-2 and vascular endothelial growth factor (VEGF). Both 14 cases of cavernous hemangioma were positive for VEGF, and negative in capillary hemangioma, there was statistical significant difference between two types of hemangioma (P < 0.05). The most tumors had a low expression of Ki-67 with a mean ± standard deviation (SD) of 6.62 ± 6.24%, whereas the mean ± SD of Bcl-2 labeling index was 36.06 ± 19.05%. According to the statistical results, the expression of Ki-67 and Bcl-2 did not correlate with age, gender, tumor size, amount of tumor and angiomatous types. Hemangioma of spleen was one benign tumor with a tendency of slow growth. Therefore, operation should be strictly selected, we recommend observation of patients with small, asymptomatic splenic lesions, which meet the radiologic criteria for hemangiomas. |
| doi_str_mv | 10.4103/0973-1482.199575 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_1866788753</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A480561021</galeid><sourcerecordid>A480561021</sourcerecordid><originalsourceid>FETCH-LOGICAL-c521i-55fca105fe105e214b451aed0f53a183e68c7454099d126002e0159e2f9665b43</originalsourceid><addsrcrecordid>eNptkc9r2zAYhsXYWNNu952KYacdnOnTD1s-ltKuhcIuKz1-KM6nzIktpVJC6H9fZU7bFYJAEtLzvkI8jH0DPlXA5U_e1LIEZcQUmkbX-gOb5I0pFUjzkU1er0_YaUpLznUthPnMToSBqhHKTNgPAUVrE6Ui0jrETSqCL_5aGqxfdGGwRXBFWvdE_gv75Gyf6OthPWP311d_Lm_Ku9-_bi8v7spWC-hKrV1rgWtHeSIBaqY0WJpzp6UFI6kyba204k0zB1FxLoiDbki4pqr0TMkz9n3sXcfwuKW0wWXYRp-fRDBVVRtTa_lGLWxP2HkXNtG2Q5davFCG6wq4gEyVR6gFeYq2D55cl4_f8dMjfB5zGrr2aICPgTaGlCI5XMdusPEJgeNeEe4d4N4Bjopy5Pzwv-1soPlr4MVJBh5GYBf6DcW06rc7ipjZlQ-7d8Xlf8UIUkgUgP904kEnBo8vOuUz2PSjUg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1866788753</pqid></control><display><type>article</type><title>21 cases reports on haemangioma of spleen</title><source>MEDLINE</source><source>Medknow Open Access Medical Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Huang, Yuan ; Mu, Guangchuan ; Qin, Xingan ; Lin, Jinling ; Li, Shaosen ; Zeng, Yanjun</creator><creatorcontrib>Huang, Yuan ; Mu, Guangchuan ; Qin, Xingan ; Lin, Jinling ; Li, Shaosen ; Zeng, Yanjun</creatorcontrib><description>The growing activity of hemangioma of spleen keeps unknown. To search theoretical basis for whether to take the operation, this study analyzed clinical data of 21 hemangioma patients, and 16 surgical specimens were analyzed immunohistochemistry of Ki-67, Bcl-2 and vascular endothelial growth factor (VEGF). Both 14 cases of cavernous hemangioma were positive for VEGF, and negative in capillary hemangioma, there was statistical significant difference between two types of hemangioma (P < 0.05). The most tumors had a low expression of Ki-67 with a mean ± standard deviation (SD) of 6.62 ± 6.24%, whereas the mean ± SD of Bcl-2 labeling index was 36.06 ± 19.05%. According to the statistical results, the expression of Ki-67 and Bcl-2 did not correlate with age, gender, tumor size, amount of tumor and angiomatous types. Hemangioma of spleen was one benign tumor with a tendency of slow growth. Therefore, operation should be strictly selected, we recommend observation of patients with small, asymptomatic splenic lesions, which meet the radiologic criteria for hemangiomas.</description><identifier>ISSN: 0973-1482</identifier><identifier>EISSN: 1998-4138</identifier><identifier>DOI: 10.4103/0973-1482.199575</identifier><identifier>PMID: 28169248</identifier><language>eng</language><publisher>India: Wolters Kluwer India Pvt. Ltd</publisher><subject>Biomarkers ; Care and treatment ; Case studies ; Diagnosis ; Hemangioma ; Hemangioma - diagnosis ; Hemangioma - metabolism ; Hemangioma - surgery ; Humans ; Immunohistochemistry ; Ki-67 Antigen - metabolism ; Proto-Oncogene Proteins c-bcl-2 - metabolism ; Splenectomy ; Splenic diseases ; Splenic Neoplasms - diagnosis ; Splenic Neoplasms - metabolism ; Splenic Neoplasms - surgery ; Treatment Outcome</subject><ispartof>Journal of cancer research and therapeutics, 2016-10, Vol.12 (4), p.1323-1323</ispartof><rights>COPYRIGHT 2016 Medknow Publications and Media Pvt. Ltd.</rights><rights>Copyright Medknow Publications & Media Pvt Ltd Oct-Dec 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c521i-55fca105fe105e214b451aed0f53a183e68c7454099d126002e0159e2f9665b43</citedby><cites>FETCH-LOGICAL-c521i-55fca105fe105e214b451aed0f53a183e68c7454099d126002e0159e2f9665b43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27435,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28169248$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Huang, Yuan</creatorcontrib><creatorcontrib>Mu, Guangchuan</creatorcontrib><creatorcontrib>Qin, Xingan</creatorcontrib><creatorcontrib>Lin, Jinling</creatorcontrib><creatorcontrib>Li, Shaosen</creatorcontrib><creatorcontrib>Zeng, Yanjun</creatorcontrib><title>21 cases reports on haemangioma of spleen</title><title>Journal of cancer research and therapeutics</title><addtitle>J Cancer Res Ther</addtitle><description>The growing activity of hemangioma of spleen keeps unknown. To search theoretical basis for whether to take the operation, this study analyzed clinical data of 21 hemangioma patients, and 16 surgical specimens were analyzed immunohistochemistry of Ki-67, Bcl-2 and vascular endothelial growth factor (VEGF). Both 14 cases of cavernous hemangioma were positive for VEGF, and negative in capillary hemangioma, there was statistical significant difference between two types of hemangioma (P < 0.05). The most tumors had a low expression of Ki-67 with a mean ± standard deviation (SD) of 6.62 ± 6.24%, whereas the mean ± SD of Bcl-2 labeling index was 36.06 ± 19.05%. According to the statistical results, the expression of Ki-67 and Bcl-2 did not correlate with age, gender, tumor size, amount of tumor and angiomatous types. Hemangioma of spleen was one benign tumor with a tendency of slow growth. Therefore, operation should be strictly selected, we recommend observation of patients with small, asymptomatic splenic lesions, which meet the radiologic criteria for hemangiomas.</description><subject>Biomarkers</subject><subject>Care and treatment</subject><subject>Case studies</subject><subject>Diagnosis</subject><subject>Hemangioma</subject><subject>Hemangioma - diagnosis</subject><subject>Hemangioma - metabolism</subject><subject>Hemangioma - surgery</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Ki-67 Antigen - metabolism</subject><subject>Proto-Oncogene Proteins c-bcl-2 - metabolism</subject><subject>Splenectomy</subject><subject>Splenic diseases</subject><subject>Splenic Neoplasms - diagnosis</subject><subject>Splenic Neoplasms - metabolism</subject><subject>Splenic Neoplasms - surgery</subject><subject>Treatment Outcome</subject><issn>0973-1482</issn><issn>1998-4138</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNptkc9r2zAYhsXYWNNu952KYacdnOnTD1s-ltKuhcIuKz1-KM6nzIktpVJC6H9fZU7bFYJAEtLzvkI8jH0DPlXA5U_e1LIEZcQUmkbX-gOb5I0pFUjzkU1er0_YaUpLznUthPnMToSBqhHKTNgPAUVrE6Ui0jrETSqCL_5aGqxfdGGwRXBFWvdE_gv75Gyf6OthPWP311d_Lm_Ku9-_bi8v7spWC-hKrV1rgWtHeSIBaqY0WJpzp6UFI6kyba204k0zB1FxLoiDbki4pqr0TMkz9n3sXcfwuKW0wWXYRp-fRDBVVRtTa_lGLWxP2HkXNtG2Q5davFCG6wq4gEyVR6gFeYq2D55cl4_f8dMjfB5zGrr2aICPgTaGlCI5XMdusPEJgeNeEe4d4N4Bjopy5Pzwv-1soPlr4MVJBh5GYBf6DcW06rc7ipjZlQ-7d8Xlf8UIUkgUgP904kEnBo8vOuUz2PSjUg</recordid><startdate>20161001</startdate><enddate>20161001</enddate><creator>Huang, Yuan</creator><creator>Mu, Guangchuan</creator><creator>Qin, Xingan</creator><creator>Lin, Jinling</creator><creator>Li, Shaosen</creator><creator>Zeng, Yanjun</creator><general>Wolters Kluwer India Pvt. Ltd</general><general>Medknow Publications and Media Pvt. Ltd</general><general>Medknow Publications & Media Pvt. Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope></search><sort><creationdate>20161001</creationdate><title>21 cases reports on haemangioma of spleen</title><author>Huang, Yuan ; Mu, Guangchuan ; Qin, Xingan ; Lin, Jinling ; Li, Shaosen ; Zeng, Yanjun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c521i-55fca105fe105e214b451aed0f53a183e68c7454099d126002e0159e2f9665b43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Biomarkers</topic><topic>Care and treatment</topic><topic>Case studies</topic><topic>Diagnosis</topic><topic>Hemangioma</topic><topic>Hemangioma - diagnosis</topic><topic>Hemangioma - metabolism</topic><topic>Hemangioma - surgery</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Ki-67 Antigen - metabolism</topic><topic>Proto-Oncogene Proteins c-bcl-2 - metabolism</topic><topic>Splenectomy</topic><topic>Splenic diseases</topic><topic>Splenic Neoplasms - diagnosis</topic><topic>Splenic Neoplasms - metabolism</topic><topic>Splenic Neoplasms - surgery</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Huang, Yuan</creatorcontrib><creatorcontrib>Mu, Guangchuan</creatorcontrib><creatorcontrib>Qin, Xingan</creatorcontrib><creatorcontrib>Lin, Jinling</creatorcontrib><creatorcontrib>Li, Shaosen</creatorcontrib><creatorcontrib>Zeng, Yanjun</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><jtitle>Journal of cancer research and therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Huang, Yuan</au><au>Mu, Guangchuan</au><au>Qin, Xingan</au><au>Lin, Jinling</au><au>Li, Shaosen</au><au>Zeng, Yanjun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>21 cases reports on haemangioma of spleen</atitle><jtitle>Journal of cancer research and therapeutics</jtitle><addtitle>J Cancer Res Ther</addtitle><date>2016-10-01</date><risdate>2016</risdate><volume>12</volume><issue>4</issue><spage>1323</spage><epage>1323</epage><pages>1323-1323</pages><issn>0973-1482</issn><eissn>1998-4138</eissn><abstract>The growing activity of hemangioma of spleen keeps unknown. To search theoretical basis for whether to take the operation, this study analyzed clinical data of 21 hemangioma patients, and 16 surgical specimens were analyzed immunohistochemistry of Ki-67, Bcl-2 and vascular endothelial growth factor (VEGF). Both 14 cases of cavernous hemangioma were positive for VEGF, and negative in capillary hemangioma, there was statistical significant difference between two types of hemangioma (P < 0.05). The most tumors had a low expression of Ki-67 with a mean ± standard deviation (SD) of 6.62 ± 6.24%, whereas the mean ± SD of Bcl-2 labeling index was 36.06 ± 19.05%. According to the statistical results, the expression of Ki-67 and Bcl-2 did not correlate with age, gender, tumor size, amount of tumor and angiomatous types. Hemangioma of spleen was one benign tumor with a tendency of slow growth. Therefore, operation should be strictly selected, we recommend observation of patients with small, asymptomatic splenic lesions, which meet the radiologic criteria for hemangiomas.</abstract><cop>India</cop><pub>Wolters Kluwer India Pvt. Ltd</pub><pmid>28169248</pmid><doi>10.4103/0973-1482.199575</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0973-1482 |
| ispartof | Journal of cancer research and therapeutics, 2016-10, Vol.12 (4), p.1323-1323 |
| issn | 0973-1482 1998-4138 |
| language | eng |
| recordid | cdi_proquest_journals_1866788753 |
| source | MEDLINE; Medknow Open Access Medical Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | Biomarkers Care and treatment Case studies Diagnosis Hemangioma Hemangioma - diagnosis Hemangioma - metabolism Hemangioma - surgery Humans Immunohistochemistry Ki-67 Antigen - metabolism Proto-Oncogene Proteins c-bcl-2 - metabolism Splenectomy Splenic diseases Splenic Neoplasms - diagnosis Splenic Neoplasms - metabolism Splenic Neoplasms - surgery Treatment Outcome |
| title | 21 cases reports on haemangioma of spleen |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T02%3A53%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=21%20cases%20reports%20on%20haemangioma%20of%20spleen&rft.jtitle=Journal%20of%20cancer%20research%20and%20therapeutics&rft.au=Huang,%20Yuan&rft.date=2016-10-01&rft.volume=12&rft.issue=4&rft.spage=1323&rft.epage=1323&rft.pages=1323-1323&rft.issn=0973-1482&rft.eissn=1998-4138&rft_id=info:doi/10.4103/0973-1482.199575&rft_dat=%3Cgale_proqu%3EA480561021%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1866788753&rft_id=info:pmid/28169248&rft_galeid=A480561021&rfr_iscdi=true |